These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9820640)

  • 1. Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia.
    Ikpeazu EV; Kaplon MK
    Eur J Haematol; 1998 Oct; 61(4):286-7. PubMed ID: 9820640
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
    Dinçol G; Kahraman R
    Am J Hematol; 2006 May; 81(5):387. PubMed ID: 16628737
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycobacterium-avium-intracellulare complex infection following 2-chlorodeoxyadenosine therapy for hairy cell leukaemia.
    Broady R; Roberts S; Hawkins T
    Leuk Lymphoma; 2000 Feb; 36(5-6):639-42. PubMed ID: 10784410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine.
    Seshadri P
    Leuk Res; 2000 Jul; 24(7):637. PubMed ID: 10979762
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of toxicity in a cladribine extravasation.
    Mateu-de Antonio J; Acuña-Reina L; Pons JC; Buisán MJ
    Ann Pharmacother; 1999; 33(7-8):873. PubMed ID: 10466922
    [No Abstract]   [Full Text] [Related]  

  • 6. Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
    Juliusson G
    Am J Hematol; 1996 Sep; 53(1):49. PubMed ID: 8813099
    [No Abstract]   [Full Text] [Related]  

  • 7. 2-chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients.
    Cohen PR; Kurzrock R
    Am J Dermatopathol; 1999 Feb; 21(1):106-8. PubMed ID: 10027536
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.
    Ravandi F; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Koller C; Challagundla P; York S; Brandt M; Luthra R; Burger J; Thomas D; Keating M; Kantarjian H
    Blood; 2011 Oct; 118(14):3818-23. PubMed ID: 21821712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Koczwara B; Spangenthal E; Bernstein SH
    Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone marrow fibrosis during therapy of hairy cell leukemia].
    Dĕdic K; Zák P
    Cesk Patol; 2004 Jan; 40(1):22-4. PubMed ID: 15035057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
    Setoodeh R; Zhang L
    Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine.
    Lenz G; Golf A; Rüdiger T; Hiddemann W; Haferlach T
    Blood; 2003 Nov; 102(9):3457-8. PubMed ID: 14568909
    [No Abstract]   [Full Text] [Related]  

  • 14. Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol.
    Espinosa Lara P; Quirós Redondo V; Aguado Lobo M; Jiménez-Reyes J
    Ann Hematol; 2017 Jul; 96(7):1209-1210. PubMed ID: 28391438
    [No Abstract]   [Full Text] [Related]  

  • 15. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hairy cell leukemia: Part II: therapy with cladribine].
    Barth J; Rummel MJ
    Med Monatsschr Pharm; 2009 Jul; 32(7):252-60. PubMed ID: 19731753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated zygomycosis: a rare cause of infection in patients with hematologic malignancies.
    Doucette KE; Galbraith PA; Bow EJ; Binda BJ; Rendina A; Embil JM
    J Trauma; 2003 Sep; 55(3):568-70. PubMed ID: 14501907
    [No Abstract]   [Full Text] [Related]  

  • 18. High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.
    Ganzel C; Gatt ME; Maly A; Ben-Yehuda D; Goldschmidt N
    Leuk Lymphoma; 2012 Jun; 53(6):1169-73. PubMed ID: 22035415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
    Beksaç M; Arat M; Idilman R
    Cancer; 1999 Jan; 85(1):242-3. PubMed ID: 9921999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of one hairy cell leukemia case with single course of cladribine].
    Zhang LJ; Qiu HX; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):336. PubMed ID: 21729604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.